Literature DB >> 16404850

Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand.

Prasit Phowthongkum1, Vichit Prasanthai, Nibhondh Udomsantisook, Chusana Suankratay.   

Abstract

Rapidly growing mycobacteria (RGM) have emerged as important human pathogens that can cause a variety of diseases. Thirty isolates of the pathogenic RGM were recovered from patients who attended King Chulalongkorn Memorial Hospital during 1997 and 2003. There were 16 isolates of Mycobacterium chelonae, ten isolates of M. fortuitum and four isolates of M. abscessus. Clinical data was available in only nine patients (five males and four females) including six M. chelonae, two M. abscessus, and one M. fortuitum. The mean age was 37 years (range: 13-62 years). The associated conditions were present in five patients including two diabetes, one HIV infection, one pregnancy, one SLE and one chronic renal failure. A wide spectrum of clinical features was observed. These included two chronic pulmonary infections, two post-traumatic wound infections, two disseminated infections, one lymphadenitis, one keratitis and respiratory colonization. AFB staining was positive in six patients (66.67%). The MIC of one M. chelonae and one M. abscessus were determined by Epsilon test. For M. chelonae, the MIC of clarithromycin, amikacin, ciprofloxacin, sulfamethoxazole and imipenem were 0.25, 2.0, 1.00, > 64, and 0.54 microg/ml, respectively. For M. abscessus, the MIC of clarithromycin, amikacin, ciprofloxacin, tetracycline and sulfamethoxazole were 0.016, 0.016, 0.038, > 16 and 0.002 microg/ml, respectively. Six of eight patients (75%) were initially treated with four first-line antituberculous drugs (isoniazid, rifampicin, pyrazinamide and ethambutol) before obtaining the culture result. Of these, three patients with pulmonary and disseminated infections improved after a prolonged course of these combinations. The patients improved after switching to specific anti-RGM antibiotics. One patient died after 10 months of therapy of four anti-tuberculous drugs. One patient with post-traumatic wound infection was cured with surgical debridement and dicloxacillin. One patient improved after treatment as acute bronchitis with oral amoxicillin. An extensive review of the literature of RGM infections in Thailand is also presented.

Entities:  

Mesh:

Year:  2005        PMID: 16404850

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  6 in total

Review 1.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

Review 2.  Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature.

Authors:  T Kampitak; G Suwanpimolkul; S Browne; C Suankratay
Journal:  Infection       Date:  2010-12-03       Impact factor: 3.553

3.  Disseminated Mycobacterium abscessus Infection Following Septic Arthritis: A Case Report and Review of the Literature.

Authors:  Shoichi Fukui; Noritaka Sekiya; Yasunobu Takizawa; Hiroshi Morioka; Hirofumi Kato; Akio Aono; Kinuyo Chikamatsu; Satoshi Mitarai; Satomi Kobayashi; Satoshi Kamei; Keigo Setoguchi
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

4.  Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand.

Authors:  Pimjai Ananta; Irin Kham-Ngam; Ploenchan Chetchotisakd; Prajuab Chaimanee; Wipa Reechaipichitkul; Wises Namwat; Viraphong Lulitanond; Kiatichai Faksri
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

5.  Clinical aspects of the Mycobacterium abscessus complexAuthors' replyClinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian AmazonBurden of non-tuberculous mycobacterial pulmonary disease in GermanyBritish Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Bras Pneumol       Date:  2018 Sep-Oct       Impact factor: 2.624

6.  Assessment of antimycobacterial activities of pure compounds extracted from Thai medicinal plants against clarithromycin-resistant Mycobacterium abscessus.

Authors:  Auttawit Sirichoat; Irin Kham-Ngam; Orawee Kaewprasert; Pimjai Ananta; Awat Wisetsai; Ratsami Lekphrom; Kiatichai Faksri
Journal:  PeerJ       Date:  2021-10-26       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.